Stocks
Arrowhead Pharmaceuticals (ARWR) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -46.0 | -19.8 | 0.00 | -3.87 | -2 829 | -29.7 | ||
| Changes by years, y/y, % | -10% | -57% | -100% | +72 983% | +123.0% | ||||
Arrowhead Pharmaceuticals. P/E
Arrowhead Pharmaceuticals. P/E, changes, %
Arrowhead Pharmaceuticals (ARWR) P/E US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/E | ? | -11.8 | -14.8 | -2 870 | 46.0 | -29.7 | -29.7 | |
| Changes by years, y/y, % | +72 703% | -1 353% | +151% | |||||
| Changes by quarters, q/q, % | +222% | +25% | +19 287% | -102% | -165% | |||
